Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 315-319

  De Mingo, Marta ^a   Morán, Alberto ^b   Sánchez Pernaute, Andrés ^a   Iniesta, Pilar ^b   Díez Valladares, Luis ^a   Pérez Aguirre, Elia ^a   De Juan, Carmen ^b   García Aranda, Cristina ^b   Díaz López, Antonio ^b   García Botella, Alejandra ^a   Martín Antona, Esteban ^a   Benito, Manuel ^b   Torres, Antonio ^a   Balibrea, José Luis ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Gastric cancer; Metalloproteinase 9; Prognosis; TIMP 1

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR CELL;

ADENOCARCINOMA; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 34047130132     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Alexander HR, Kelsen DP, Tepper JE: Cancer of the stomach. In: DeVita VT, Hellman S, Rosenberg SA (Eds). Cancer. Principles and practice of oncology. 5th Edition. Philadelphia: Lippincott-Raven Publisher, 1997; pp. 1021-1022.
2. Bashyam MD: Understanding cancer metastasis. Cancer 2002; 94:1821-1829.
3. Bonomi P: Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol 2002; 29:78-86.
4. Wagenaar-Miller RA, Gorden L, Matrisian LM: Matrix metalloproteinases in colorectal cancer. Cancer Metastasis Rev 2004; 23:119-135.
5. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277:225-228.
6. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation of decorin by matrix metalloproteinases: Identification ofthe cleavage sites, kinetic analyzes and transforming growth-beta 1 release. Biochem J 1997; 322:809-814.
7. Xu J, Rodriguez D, Petitclerc C, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC, Yuen SM: Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001; 154:1069-1079.
8. Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, Miwa K, Sugiyama K, Sasaki T: Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer 2000; 3:63-70.
9. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000; 18:1135-1149.
10. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, Basset P: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993; 90:1843-1847.
11. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T, Sugimachi K: Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000; 6:3581-3584.
12. Zhang S, Li L, Lin J-Y, Lin H: Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 2003; 9:899-904.
13. Hidalgo M, Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001; 93:178-193.
14. Mimori K, Mori M, Shiraishi T, Fujie T, Baba K, Haraguchi M, Abe R, Ueo H, Akiyoshi T: Clinical signification of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 1997; 76:531-536.
15. Sayegh ME, Sano T, Dexter S, Katai H, Fukagawa T, Sasako M: TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer 2004; 7:140-148.
16. Becker KF, Keller G, Hoefler H: The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 2000; 9:5-11.
17. del Casar Lizcano JM, Vizoso Piñeiro F, González Sánchez LO, Martín Suárez A, Cuesta Fernández E, Díez Santiesteban MC: Expression and clinical significance of collagenase-3 (MMP-13) in gastric cancer. Gastroenterol Hepatol 2003; 26:1-7.
18. Elnmer A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Tochiori S, Endou Y, Sasaki T: Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 2003; 6:30-38.
19. Liu XP, Kawauchi S, Oga A, Tsushimi K, Tsushimi M, Furuya T, Sasaki K: Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res 2002; 93:291-295.